suplatast tosilate has been researched along with azelastine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanashiro, K; Kinjoh, K; Koga, T; Kosugi, T; Nakamura, M; Tamaki, N | 1 |
| Hanashiro, K; Kosugi, T; Nakamura, M; Nakasone, T; Sunagawa, M; Tokeshi, Y | 1 |
| Katayama, I; Nishioka, K; Sasaki, G; Satoh, T; Wu, MH; Yokozeki, H | 1 |
3 other study(ies) available for suplatast tosilate and azelastine
| Article | Year |
|---|---|
Inhibitory effect of azelastine hydrochloride and suplatast tosilate on airway responses in sensitized rats following exposure to antigen.
Topics: Airway Resistance; Animals; Anti-Allergic Agents; Antigens; Arylsulfonates; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Immunization; Immunoglobulin E; Male; Phthalazines; Rats; Rats, Wistar; Sulfonium Compounds | 1997 |
Azelastine and suplatast shorten the distribution half-life of IgE in rats.
Topics: Animals; Anti-Allergic Agents; Arylsulfonates; Enzyme-Linked Immunosorbent Assay; Half-Life; Immunoglobulin E; Male; Phthalazines; Rats; Rats, Wistar; Sulfonium Compounds | 2002 |
Suplatast tosilate inhibits eosinophil production and recruitment into the skin in murine contact sensitivity.
Topics: Administration, Oral; Animals; Anti-Allergic Agents; Arylsulfonates; Benzimidazoles; Cell Count; Dermatitis, Allergic Contact; Disease Models, Animal; Dose-Response Relationship, Drug; Eosinophils; Female; Interleukin-4; Interleukin-5; Leukocyte Count; Lymph Nodes; Mice; Phthalazines; Picryl Chloride; Skin; Spleen; Sulfonium Compounds | 2003 |